GI Repair Blend
Technical Monograph
The Gastrointestinal Repair Blend is a synergistic combination of BPC-157 and Larazotide (or similar tight-junction regulators). It is subjected to investigation for the repair of the intestinal epithelial barrier.
Mechanism of Action
BPC-157 provides broad tissue cytoprotection and angiogenic repair mechanisms to the intestinal mucosa. The secondary regulator addresses the paracellular space, antagonizing zonulin pathways to close defective tight junctions between enterocytes.
Pharmacological Detail
BPC-157 leverages the BP-3 receptor and FAK pathways. Tight-junction regulators (like Larazotide) interfere with the molecular disassembly of ZO-1 and occludin complexes.
Pharmacodynamics
Observed to rapidly restore intestinal transepithelial electrical resistance (TEER) in in vitro models of hyperpermeability.
Pharmacokinetics
Designed for targeted localized activity along the GI tract prior to systemic degradation.
Preclinical Observations & In Vitro Data
Models for Celiac, Crohn's, and hyperpermeability syndromes are the primary focus of this specific combination. Data cited from published literature; not a product claim.
Abstract Highlights
- Significant modulation of tight junction permeability
- Angiogenic signaling repair for mucosal ulcerations
- Downregulation of prominent inflammatory cytokines
- Mechanisms addressing macro-molecular intestinal leakage
Chemical Specifications
Material Handling & Stability
Strict Notice
THIS COMPOUND IS PRODUCED FOR LABORATORY RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION. MATERIAL DATA SHEETS AND LABORATORY GUIDELINES SHOULD BE CONSULTED PRIOR TO HANDLING.